Trenbolone Enanthate
A long-ester form of trenbolone, an extremely potent 19-nor androgen that does not aromatise but is strongly progestogenic. It produces dramatic strength and recomposition effects but carries the heaviest side-effect burden of common anabolic steroids — night sweats, insomnia, aggression, cardiovascular strain and 'tren cough'. Almost all data are veterinary or anecdotal; no human trials exist.
01 Overview
Trenbolone is a 19-nortestosterone with an 11,9-diene structure that makes it bind the androgen and progesterone receptors extremely strongly while being completely resistant to aromatase. It was developed only for veterinary and livestock use (as the acetate); the enanthate ester is a purely underground bodybuilding formulation with no human clinical development, which is why its research score sits low despite widespread use — the evidence is essentially veterinary pharmacology plus dense anecdote.
Its potency cuts both ways: users report rapid, high-quality strength and body-recomposition, but also the most severe and characteristic side effects of any popular steroid — heavy night sweats, insomnia, mood disturbance and aggression, elevated prolactin/progestogenic effects, cardiovascular strain, and reduced aerobic capacity. Because it does not aromatise, low-oestrogen effects can occur if run without an aromatising base. The enanthate ester extends dosing to twice weekly versus the acetate's every-other-day schedule.
02 Mechanism
Exceptionally high-affinity androgen-receptor agonist that also activates the progesterone receptor; resistant to aromatase and 5-alpha reductase, driving potent anabolic and nutrient-partitioning effects with strong progestogenic activity.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Common | 200–300 mg/wk | IM | Very potent; low doses are effective. Injected twice weekly. |
| Heavy | 400–500 mg/wk | IM | Side-effect burden rises steeply; not advisable. |
Ester comparison
| Ester | Half-life | Injection freq. | Testosterone by mass |
|---|
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Rapid strength and muscle gainPotent anabolic and anti-catabolic effect demonstrated in livestock; human evidence is anecdotal. | Preclinical | ||
| Body recomposition / fat lossStrong nutrient-partitioning effect; animal studies show simultaneous lean gain and fat reduction. | Preclinical | ||
| Increased feed efficiency / nutrient partitioningThe basis of its veterinary use for livestock growth. | Preclinical |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Night sweats and insomniaProfuse night sweating and disrupted sleep are hallmark trenbolone effects. | Moderate | Very common | Anecdotal | |
| Mood disturbance and aggressionIrritability, anxiety and aggression are commonly reported; can be marked. | Moderate | Common | Anecdotal | |
| Progestogenic effects (prolactin-related)Libido/erectile problems and gynaecomastia via progesterone-receptor activity and prolactin elevation, despite no aromatisation. | Moderate | Common | Anecdotal | |
| Cardiovascular strain and reduced enduranceMarked HDL suppression, blood pressure elevation and notably reduced aerobic capacity. | Severe | Common | Anecdotal |
06 Commonly used with
What trenbolone is combined with, and why. This is about intent rather than safety — the interactions table below covers what is dangerous. Nothing here is listed without what it costs.
| Compound | Frequency | Purpose & trade-off |
|---|---|---|
| Stacked compounds | ||
| Testosteronebase | Testosterone base sustains libido and wellbeing suppressed by trenbolone, matched to the long enanthate ester.Trade-off: Adds aromatisation and estrogenic sides that need separate management. | |
| Testosterone enanthatematched ester | Enanthate testosterone shares tren enanthate's dosing schedule for a lower-frequency long-ester cycle.Trade-off: Long esters make sides slow to resolve if trenbolone becomes intolerable. | |
| BoldenoneEQ | Boldenone adds endurance and steady lean gains alongside tren in longer recomposition blocks.Trade-off: Combined RBC stimulation raises haematocrit, adding to trenbolone's cardiovascular strain. | |
| Support & ancillaries | ||
| Cabergolinedopamine agonist | Manages prolactin-related sexual side effects sometimes attributed to the 19-nor trenbolone.Trade-off: Can cause nausea and hypotension, and not all tren sexual sides are prolactin-mediated. | |
| Post-cycle | ||
| TamoxifenPCT | Restarts the HPTA once the long tren enanthate ester has cleared from the system.Trade-off: PCT must be delayed for the long ester, and recovery can be slow after deep trenbolone suppression. | |